Akiko Miyagi-Maeshima

14PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 16, 2026
Association between CD79B expression and polatuzumab vedotin efficacy, and therapy-induced changes in CD79B expression in diffuse large B-cell lymphoma.

|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

|Oct 23, 2024
Widespread benign HNF1β-positive solid nests from the urethral diverticulum to the bladder neck: Is it a mesonephric remnant?

Takahiro Kirisawa, Akiko Miyagi Maeshima, Tomoya Okuno

|Jul 26, 2024
Histopathology of peritonitis due to infectious mononucleosis with background Chlamydia trachomatis infection: A case report and literature review.

Yuto Kaimi, Tomoaki Naka, Hiroshi Yoshida

|Feb 13, 2024
Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy.

Yuto Kaimi, Yuka Takahashi, Hirokazu Taniguchi

|May 17, 2022
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.

Suguru Fukuhara, Yuji Oshikawa-Kumade, Yasunori Kogure

Pageof 3

Frequent Collaborators

4 joint publications

Shinichi Makita

3 joint publications

Dai Maruyama

3 joint publications

Hiromichi Matsushita

2 joint publications

Junji Koya